Parkin and Its Role in Parkinson’s Disease

Parkinson's Disease

Volumn , Issue , 2004, Pages 129-138

  Gasser, Thomas ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85160154574     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203508596-23     Document Type: Chapter

References (63)

1. Gasser T., Overview of the genetics of parkinsonism, Adv. Neurol., 91:143–152, 2003.
2. Polymeropoulos, M. H., Lavedan, C., Leroy, E. et al., Mutation in the α-synuclein gene identified in families with Parkinson’s disease, Science, 276:2045–2047, 1997.
3. Ishikawa, A., Tsuji, S., Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism, Neurology, 47(1):160–166, 1996.
4. Ichinose, H., Ohye, T., Takahashi, E. et al., Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene, Nat. Genet., 8(3):236–242, 1994.
5. Matsumine, H., Saito, M., Shimoda-Matsubayashi, S. et al., Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2–27, Am. J. Hum. Genet., 60(3):588–596, 1997.
6. Tassin, J., Durr, A., de Broucker, T. et al., Chromosome 6-linked autosomal recessive early-onset parkinsonism: Linkage in european and algerian families, extension of the clinical spectrum, and evidence of a small homozygous deletion in one family, Am. J. Hum. Genet., 63(1):88–94, 1998.
7. Jones, A. C., Yamamura, Y., Almasy, L. et al., Autosomal recessive juvenile parkinsonism maps to 6q25.2-q27 in four ethnic groups: Detailed genetic mapping of the linked region, Am. J. Hum. Genet., 63(1):80–87, 1998.
8. Kitada, T., Asakawa, S., Hattori, N. et al., Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism, Nature, 392:605–608, 1998.
9. Hattori, N., Kitada, T., Matsumine, H. et al., Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: Evidence for variable homozygous deletions in the Parkin gene in affected individuals, Ann. Neurol., 44(6):935–941, 1998.
10. Lücking, C. B., Abbas, N., Dürr, A. et al., Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism. The European Consortium on Genetic Susceptibility in Parkinson’s Disease and the French Parkinson’s Disease Genetics Study Group, Lancet, 352(9137):1355–1356, 1998.
11. Abbas, N., Lücking, C. B., Ricard, S. et al., A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe, Hum. Mol. Genet., 8(4):567–574, 1999.
12. Lücking, C. B., Dürr, A., Bonifati, V. et al., Association between Early-Onset Parkinson’s Disease and Mutations in the Parkin Gene, N. Engl. J. Med., 342(21):1560–1567, 2000.
13. Lücking, C. B., Bonifati, V., Periquet, M., Vanacore, N., Brice, A., Meco, G., Pseudo-dominant inheritance and exon 2 triplication in a family with parkin gene mutations, Neurology, 57(5):924–7, 2001.
14. Periquet, M., Lücking, C. B., Vaughan, J. R. et al., Origin of the Mutations in the parkin Gene in Europe: Exon Rearrangements Are Independent Recurrent Events, whereas Point Mutations May Result from Founder Effects, Am. J. Hum. Genet., 68(3):617–626, 2001.
15. Lohmann, E., Periquet, M., Bonifati, V. et al., How much phenotypic variation can be attributed to parkin genotype? Ann. Neurol., 54(2):176–185, 2003.
16. Tassin, J., Durr, A., Bonnet, A. M. et al., Levodoparesponsive dystonia: GTP cyclohydrolase I or parkin mutations? Brain, 123 (Pt. 6):1112–1121, 2000.
17. Yamamura, Y., Hattori, N., Matsumine, H., Kuzuhara, S., Mizuno, Y., Autosomal recessive early-onset parkinsonism with diurnal fluctuation: Clinicopathologic characteristics and molecular genetic identification, Brain Dev., 22 Suppl., 1:87–91.:87–91, 2000.
18. Khan, N. L., Graham, E., Critchley, P. et al., Parkin disease: A phenotypic study of a large case series, Brain, 126 (Pt. 6): 1279–1292, 2003.
19. Inzelberg, R., Hattori, N., Nisipeanu, P. et al., Camptocormia, axial dystonia, and parkinsonism: Phenotypic heterogeneity of a parkin mutation, Neurology, 60(8):1393–1394, 2003.
20. Bruno, M. K., Ravina, B., Garraux, G. et al., Exerciseinduced dystonia as a preceding symptom of familial Parkinson’s disease, Mov. Disord., 19(2):228–30, 2004.
21. Kuroda, Y., Mitsui, T., Akaike, M., Azuma, H., Matsumoto, T., Homozygous deletion mutation of the parkin gene in patients with atypical parkinsonism, J. Neurol. Neurosurg. Psychiatry, 71(2):231–234, 2001.
22. Periquet, M., Latouche, M., Lohmann, E. et al., Parkin mutations are frequent in patients with isolated earlyonset parkinsonism, Brain, 126(Pt 6):1271–1278, 2003.
23. Pramstaller, P. P., Kis, B., Eskelson, C. et al., Phenotypic variability in a large kindred (Family LA) with deletions in the parkin gene, Mov. Disord,. 17(2):424–426, 2002.
24. Rawal, N., Periquet, M., Lohmann, E. et al., New parkin mutations and atypical phenotypes in families with autosomal recessive parkinsonism, Neurology, 60(8):1378–81, 2003.
25. Klein, C., Pramstaller, P. P., Kis, B. et al., Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: Expanding the phenotype, Ann. Neurol., 48(1):65–71, 2000.
26. Khan, N. L., Brooks, D. J., Pavese, N. et al., Progression of nigrostriatal dysfunction in a parkin kindred: An [18F]dopa PET and clinical study, Brain, 125 (Pt. 10):2248–2256, 2002.
27. Hilker, R., Klein, C., Ghaemi, M. et al., Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene, Ann. Neurol., 49(3):367–376, 2001.
28. Farrer, M., Chan, P., Chen, R. et al., Lewy bodies and parkinsonism in families with parkin mutations, Ann. Neurol., 50(3):293–300, 2001.
29. Lincoln, S. J., Maraganore, D. M., Lesnick, T. G. et al., Parkin variants in North American Parkinson’s disease: Cases and controls, Mov. Disord., 18(11):1306–11, 2003.
30. Maruyama, M., Ikeuchi, T., Saito, M. et al., Novel mutations, pseudo-dominant inheritance, and possible familial affects in patients with autosomal recessive juvenile parkinsonism, Ann. Neurol., 48(2):245–250, 2000.
31. Satoh, J., Kuroda, Y., Association of codon 167 Ser/Asn heterozygosity in the parkin gene with sporadic Parkinson’s disease, Neuroreport., 10(13):2735–2739, 1999.
32. Lücking, C. B., Chesneau, V., Lohmann, E. et al., Coding polymorphisms in the parkin gene and susceptibility to Parkinson disease, Arch. Neurol., 60(9):1253-1256, 2003.
33. West, A. B., Maraganore, D., Crook, J. et al., Functional association of the parkin gene promoter with idiopathic Parkinson’s disease, Hum. Mol. Genet., 11(22):2787–2792, 2002.
34. Klein, C., Schumacher, K., Jacobs, H. et al., Association studies of Parkinson’s disease and parkin polymorphisms, Ann. Neurol., 48(1):126–127, 2000.
35. Mellick, G. D., Buchanan, D. D., Hattori, N. et al., The parkin gene S/N167 polymorphism in Australian Parkinson’s disease patients and controls, 7(2):89–91, 2001.
36. Oliveira, S. A., Scott, W. K., Nance, M. A. et al., Association study of Parkin gene polymorphisms with idiopathic Parkinson disease, Arch. Neurol., 60(7):975–980, 2003.
37. Wang, M., Hattori, N., Matsumine, H. et al., Polymorphism in the parkin gene in sporadic Parkinson’s disease, Ann. Neurol., 45(5):655–658, 1999.
38. Ujike, H., Yamamoto, M., Kanzaki, A., Okumura, K., Takaki, M., Kuroda, S., Prevalence of homozygous deletions of the parkin gene in a cohort of patients with sporadic and familial Parkinson’s disease, Mov. Disord., 16(1):111–113, 2001.
39. Takahashi, H., Ohama, E., Suzuki, S. et al., Familial juvenile parkinsonism: Clinical and pathologic study in a family, Neurology, 44(3 Pt. 1):437–441, 1994.
40. van De Warrenburg, B. P., Lammens, M., Lücking, C. B. et al., Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations, Neurology, 56(4):555-557, 2001.
41. Mori, H., Kondo, T., Yokochi, M. et al., Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q, Neurology, 51(3):890-892, 1998.
42. Gu, W. J., Corti, O., Araujo, F. et al., The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates, Neurobiol Dis., 14(3):357–64, 2003.
43. Portman, A. T., Giladi, N., Leenders, K. L. et al., The nigrostriatal dopaminergic system in familial early onset parkinsonism with parkin mutations, Neurology, 56(12):1759–1762, 2001.
44. Leenders, K. L., Oertel, W. H., Parkinson’s disease: Clinical signs and symptoms, neural mechanisms, positron emission tomography, and therapeutic interventions, Neural Plast., 8(1–2):99–110, 2001.
45. Thobois, S., Ribeiro, M. J., Lohmann, E. et al., Youngonset Parkinson disease with and without parkin gene mutations: A fluorodopa F 18 positron emission tomography study, Arch. Neurol., 60(5):713–718, 2003.
46. Shimura, H., Hattori, N., Kubo, S. et al., Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase [In Process Citation], Nat. Genet., 25(3):302-305, 2000.
47. Zhang, Y., Gao, J., Chung, K. K., Huang, H., Dawson, V. L., Dawson, T. M., Parkin functions as an E2-dependent ubiquitinprotein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1, Proc. Natl. Acad. Sci., U.S.A., 97(24):13354–13359, 2000.
48. McNaught, K. S., Olanow, C. W., Proteolytic stress: A unifying concept for the etiopathogenesis of Parkinson’s disease, Ann. Neurol., 53 Suppl., 3:S73–84; discussion S84–6, 2003.
49. Shimura, H., Schlossmacher, M. G., Hattori, N. et al., Ubiquitination of a new form of alpha-synuclein by parkin from human brain: Implications for Parkinson’s disease, Science, 293(5528):263–269, 2001.
50. Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y., Takahashi, R., An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin, Cell, 105(7):891–902, 2001.
51. Choi, P., Snyder, H., Petrucelli, L. et al., SEPT5 v2 is a parkin-binding protein, Brain Res. Mol. Brain Res., 117(2):179–89, 2003.
52. Chung, K. K., Zhang, Y., Lim, K. L. et al., Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: Implications for Lewy-body formation in Parkinson disease, Nat. Med., 7(10):1144–1150, 2001.
53. Yang, Y., Nishimura, I., Imai, Y., Takahashi, R., Lu, B., Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila, Neuron, 37(6):911–924, 2003.
54. Darios, F., Corti, O., Lücking, C. B., et al. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death, Hum. Mol. Genet., 12(5):517–26, 2003.
55. Hyun, D. H., Lee, M., Hattori, N. et al., Effect of wildtype or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome, J. Biol. Chem., 277(32):28572–7, 2002.
56. Petrucelli, L., O’Farrell, C., Lockhart, P. J. et al., Parkin protects against the toxicity associated with mutant alpha-synuclein: Proteasome dysfunction selectively affects catecholaminergic neurons, Neuron, 36(6):1007–19, 2002.
57. Oluwatosin-Chigbum Y., Robbins, A., Scott, C. W. et al., Parkin suppresses wild-type alpha-synucleininduced toxicity in SHSY-5Y cells, Biochem. Biophys. Res. Commun., 309(3):679-84, 2003.
58. Kim, S. J., Sung, J. Y., Um, J. W. et al., Parkin cleaves intracellular alpha-synuclein inclusions via the activation of calpain, J. Biol. Chem., 278(43):41890-9, 2003.
59. Goldberg, M. S., Fleming, S. M., Palacino, J. J. et al., Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons, J. Biol. Chem., 2003.
60. Itier, J. M., Ibanez, P., Mena, M. A. et al., Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse, Hum. Mol. Genet., 12(18):2277–2291, 2003.
61. Palacino, J. J., Sagi, D., Goldberg, M. S. et al., Mitochondrial dysfunction and oxidative damage in Parkindeficient mice, J. Biol. Chem, 2004.
62. Mizuno, Y., Yoshino, H., Ikebe, S. et al., Mitochondrial dysfunction in Parkinson’s disease, Ann. Neurol., 44(3 Suppl., 1):S99–109, 1998.
63. Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., Pallanck, L. J., Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants, Proc. Natl. Acad. Sci., U.S.A. 100(7): 4078–4083, 2003.